The knockout of PTPN22 or the inhibition of its enzymatic function can promote BCR triggered CLL cell apoptosis, indicating that PTPN22 may protect malignant cells from antigen receptor induced death by inhibiting or promoting different pathways downstream of BCR (Negro et al., 2012). This evidence concerns the gene PTPN22 and B-cell chronic lymphocytic leukemia.